Brian A Walker, PhD^1*, Paola E Leone, PhD^1*, Nicholas J Dickens, DPhil^1*, Matthew W Jenner, MD^1*, Laura Chiecchio^2*, GianPaolo Dagrada^2*, Fiona M Ross, DPhil^2*, Faith E Davies, MD^1* and Gareth J Morgan, MD, PhD¹

¹Section of Haemato-Oncology, Institute of Cancer Research, London, United Kingdom
²LRF UK Myeloma Forum Cytogenetics Group, Wessex Regional Genetics Laboratory, Salisbury, United Kingdom

Marc J. Braunstein^1*, Fabien Campagne, PhD^2*, Piali Mukherjee^2*, Daniel Ruben Carrasco, M.D., Ph.D.^3*, Kumar Sukhdeo^3*, Alexei Protopopov^3*, Kenneth C Anderson, MD⁴ and Olcay Batuman, MD¹

¹Medicine, Hematology/Oncology, SUNY Downstate Medical Center, Brooklyn, NY
²Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, NY
³Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Dong-Joon Min, PhD^1*, Julia Meyer, BS^1*, Eva Martinez-Garcia, PhD^1*, Josh Lauring, MD, PhD² and Jonathan D. Licht, MD¹

¹Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
²Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

Xavier Leleu, MD, PhD¹, Fangxin Hong, PhD^2*, Aldo M. Roccaro, MD, PhD³, Xiaoying Jia^3*, Antonio Sacco^3*, Anne-Sophie Moreau, MD^1*, Hai Ngo^3*, Abdel kareem Azab, PhD^3*, Feda Azab^3*, Molly Melhem^3*, Kenneth C. Anderson, MD^3* and Irene M. Ghobrial, MD^3*

¹Service des Maladies du Sang, Hopital Huriez, CHRU Lille, Lille, France
²Biostatistics and Computational Biology, Dana-Farber Cancer Institute
³Dana-Farber Cancer Institute, Boston, MA

Norma C. Gutiérrez^*, Maria Eugenia Sarasquete^*, Manuel Delgado^*, Patricia Martín-Jiménez^*, Carmen Chillón^*, Isabel M. Isidro^*, Teresa Prieto^*, Ramon García-Sanz^*, Jesus M. Hernández^*, Marcos González^* and Jesus F San Miguel

Hematology, Hospital Universitario de Salamanca; Centro de Investigación del Cáncer (CIC, IBMCC USAL-CSIC), Salamanca, Spain

Aldo M Roccaro¹, Antonio Sacco^1*, Changzhong Chen^1*, Xavier Leleu^1*, Judith Runnels^1*, Feda Azab^1*, Abdel Kareem Azab^1*, Xiaoying Jia^1*, Hai T Ngo^1*, Molly R. Melhem^1*, Nicholas Burwick^1*, Phong Quang^1*, Lyuba Varticovski^2*, Carl D Novina^1*, Barrett J. Rollins^1*, Kenneth C. Anderson^1* and Irene M. Ghobrial^1*

¹Dana-Farber Cancer Institute, Boston, MA
²National Cancer Center, Bethesda, MD

Travis J. Henry, PhD and Rafael Fonseca, MD^*

Hematology, Mayo Clinic Scottsdale, Scottsdale, AZ

Herve Avet Loiseau, MD, PhD¹, Cheng Li^2*, Florence Magrangeas^1*, Catherine Guerin^1*, Wilfried Gouraud^1*, Jean-Luc Harousseau^1*, Michel Attal, MD³, Gerald Marit^4*, Claire Mathiot^5*, Thierry Facon⁶, Philippe Moreau^1*, Kenneth C Anderson, MD⁷, Loic Campion, MD^8*, Nikhil C. Munshi, MD⁹ and Stephane Minvielle^1*

¹Hematology Department, Hopital de Nantes, Nantes, France
²Department of Biostatistics and Department of Biostatistics and Computational Biology, Harvard School of Public Health and Dana-Farber Cancer Institute, Boston
³Hopital Purpan, Toulouse, France
⁴Hematology, CHU de Bordeaux, Bordeaux, France
⁵Department of Hematology, Institut Curie, France
⁶Service d'Hématologie, CHRU Lille, Lille, France
⁷Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁸Statistics, Centre Gauducheau, Saint-Herblain, France
⁹Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston VA Cancer Healthcare System, Boston, MA